Martyn A French Selected Research

Immune Reconstitution Inflammatory Syndrome

1/2019	Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome Is Associated With Dysregulation of IL-7/IL-7 Receptor Signaling Pathway in T Cells and Monocyte Activation.
1/2019	Association Between Plasma Antibody Responses and Risk for Cryptococcus-Associated Immune Reconstitution Inflammatory Syndrome.
7/2018	Transcriptomic Predictors of Paradoxical Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
10/2017	Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
1/2016	Aberrant Inflammasome Activation Characterizes Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
2/2015	Plasma interleukin-18 levels are a biomarker of innate immune responses that predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome.
12/2014	Tuberculosis (TB)-associated immune reconstitution inflammatory syndrome in TB-HIV co-infected patients in Malaysia: prevalence, risk factors, and treatment outcomes.
11/2013	Chemokine levels and chemokine receptor expression in the blood and the cerebrospinal fluid of HIV-infected patients with cryptococcal meningitis and cryptococcosis-associated immune reconstitution inflammatory syndrome.
11/2013	TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens.
8/2013	Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martyn A French Research Topics

Disease

29	Immune Reconstitution Inflammatory Syndrome 01/2019 - 06/2002
17	Infections 01/2019 - 10/2002
16	HIV Infections (HIV Infection) 01/2017 - 12/2006
12	Tuberculosis (Tuberculoses) 01/2016 - 02/2006
9	Cryptococcal Meningitis 01/2019 - 08/2013
6	Cryptococcosis 01/2019 - 08/2013
6	Inflammation (Inflammations) 12/2018 - 11/2002
5	Acquired Immunodeficiency Syndrome (AIDS) 10/2017 - 05/2003
4	Opportunistic Infections (Opportunistic Infection) 10/2009 - 07/2004
3	Multiple Sclerosis 01/2021 - 01/2018
3	Coinfection 01/2016 - 05/2012
3	Neoplasms (Cancer) 08/2015 - 11/2010
3	Viremia 06/2015 - 03/2005
3	Hepatitis 05/2013 - 11/2002
2	Pneumococcal Infections 01/2017 - 08/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2015 - 01/2014
2	Hepatitis B 01/2014 - 02/2011
2	Autoimmune Diseases (Autoimmune Disease) 04/2013 - 01/2009
2	Disease Progression 02/2013 - 01/2006
2	Fibrosis (Cirrhosis) 06/2011 - 11/2003
2	Hypersensitivity (Allergy) 08/2004 - 07/2004
1	COVID-19 01/2020
1	Clinical Deterioration 10/2017
1	Cataract (Cataracts) 12/2016
1	Macular Degeneration (Age-Related Maculopathy) 12/2015
1	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2015
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 10/2015
1	Necrosis 04/2015
1	Brain Diseases (Brain Disorder) 02/2014
1	Vascular Diseases (Vascular Disease) 02/2014
1	Job Syndrome (Hyper-IgE Syndrome) 08/2013
1	Communicable Diseases (Infectious Diseases) 08/2013
1	Primary Immunodeficiency Diseases 04/2013

Drug/Important Bio-Agent (IBA)

12	Immunoglobulin G (IgG)IBA 01/2019 - 06/2002
11	AntibodiesIBA 01/2020 - 07/2009
9	AntigensIBA 11/2013 - 11/2003
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2010
8	CytokinesIBA 01/2017 - 06/2002
5	Proteins (Proteins, Gene)FDA Link 11/2016 - 02/2013
5	Interleukin-6 (Interleukin 6)IBA 08/2015 - 10/2002
4	EnzymesIBA 12/2018 - 06/2002
4	InterferonsIBA 06/2011 - 11/2003
3	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 02/2011
3	RNA (Ribonucleic Acid)IBA 01/2017 - 06/2011
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2006 - 06/2002
2	Interleukin-5 (Interleukin 5)IBA 10/2017 - 12/2010
2	VaccinesIBA 01/2017 - 08/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2016 - 06/2011
2	interleukin-21 (interleukin 21)IBA 10/2015 - 08/2013
2	Interleukin-18 (Interleukin 18)IBA 02/2015 - 12/2010
2	Mycobacterium tuberculosis antigensIBA 11/2013 - 11/2012
2	HLA-B Antigens (HLA-B)IBA 08/2013 - 02/2013
2	Alanine Transaminase (SGPT)IBA 05/2013 - 11/2002
2	Interferon-gamma (Interferon, gamma)IBA 07/2011 - 11/2003
2	C-Reactive ProteinIBA 06/2011 - 11/2010
2	Immunoglobulin M (IgM)IBA 07/2009 - 08/2007
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2002 - 06/2002
1	Volatile Fatty AcidsIBA 01/2021
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2019
1	InterleukinsIBA 01/2019
1	LipidsIBA 12/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018
1	Inflammation MediatorsIBA 12/2018
1	HLA-B57 antigenIBA 11/2017
1	Interleukin-7 (Interleukin 7)IBA 10/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	LigandsIBA 04/2016
1	N 30IBA 04/2016
1	InflammasomesIBA 01/2016
1	Ranibizumab (Lucentis)FDA Link 12/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2015
1	Interferon-alpha (Interferon Alfa)IBA 02/2014
1	HDL CholesterolIBA 01/2014
1	Chemokine ReceptorsIBA 11/2013
1	ChemokinesIBA 11/2013
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2013
1	Fluconazole (Zonal)FDA LinkGeneric 08/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2013
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2013
1	Triglycerides (Triacylglycerol)IBA 05/2013
1	Interleukin-10 (Interleukin 10)IBA 05/2013
1	Protein Tyrosine PhosphatasesIBA 04/2013
1	Human Immunodeficiency Virus ProteinsIBA 02/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2013
1	LipopolysaccharidesIBA 07/2011
1	Interleukin-8 (Interleukin 8)IBA 06/2011
1	fibrin fragment D (D-dimer)IBA 06/2011
1	Hyaluronic Acid (Hyaluronan)IBA 06/2011
1	Chemokine CXCL10IBA 11/2010
1	HIV AntigensIBA 08/2010
1	Fc Receptors (Fc Receptor)IBA 08/2010
1	Fc gamma receptor IIAIBA 08/2010
1	Tuberculin (PPD)IBA 12/2009

Therapy/Procedure

26	Therapeutics 01/2019 - 10/2002
21	Art Therapy 01/2019 - 02/2007
12	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 06/2002
1	Phototherapy (Light Therapy) 01/2020
1	Vitrectomy 12/2016
1	Intraocular Injections 12/2015